LumiraDx gets approval for its COVID-19 Antigen Test in India
Diagnostics testing company LumiraDx has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in...
Alembic Pharma gets USFDA nod for Palbociclib Capsules
Alembic Pharmaceuticals Limited has announced receiving tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Palbociclib...
REME HALO inactivates levels of SARS-COV-2 by 99.9%: Zeco Aircon Group Study
Zeco in partnership with RGF Environmental group has published the results of a third-party study that claim REME HALO with photo hydro ionisation (PHI)...
OncoSec announces first subjects dosed in Phase 1 trial of COVID-19 vaccine candidate
OncoSec Medical Inc has announced that it has dosed several subjects in its Phase 1 clinical trial of CORVax12.
According to the company, it is...
New findings on brain acquiring essential omega-3 fatty acids
Scientists at the National Institutes of Health and colleagues have developed a zebrafish model that provides new insight into how the brain acquires essential...
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol: Ionis
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
FlowMetric introduces ‘breakthrough’ Covid-19 antibody test
FlowMetric has launched a 'powerful advancement' in Covid-19 antibody testing that the company said delivers exceptional performance compared to existing tests on the global...
GSK and Medicago commence Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Medicago and GSK have announced the beginning of Phase 2/3 clinical trials of plant-derived vaccine candidate for Covid-19.
The study is being done to assess...
Kinetic unveils UVC light-based sanitiser that kills 99.9% of coronavirus in 15 minutes
Kinetic Communications Ltd; a member of the Kinetic Group, has introduced 'UV WARRIOR', a portable disinfector that 'sanitises all daily objects and any room...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...